financetom
Business
financetom
/
Business
/
US FDA approves syringe version of Argenx's immune disorder drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves syringe version of Argenx's immune disorder drug
Apr 10, 2025 3:16 PM

April 10 (Reuters) - The U.S. Food and Drug

Administration has approved a pre-filled syringe version of

Netherlands-based Argenx SE's blockbuster immune

disorder drug, Vyvgart, giving patients the more convenient

option of at-home self administration, the company said on

Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Starbucks Stock Today?
What's Going On With Starbucks Stock Today?
Sep 25, 2025
Starbucks Corporation ( SBUX ) announced a sweeping restructuring initiative this week, including the closure of coffee shops and workforce reductions, as part of its Back to Starbucks ( SBUX ) turnaround strategy. The plan, approved by the board of directors in an exchange filing on September 23, 2025, aims to enhance the customer experience and allocate resources more directly...
Musk's xAI to provide Grok chatbot to US federal agencies
Musk's xAI to provide Grok chatbot to US federal agencies
Sep 25, 2025
Sept 25 (Reuters) - Elon Musk's xAI has struck a deal with the U.S. General Services Administration (GSA) to provide the artificial intelligence startup's Grok chatbot to federal agencies, the government's procurement arm said on Thursday. The contract underscores Washington's push to expand the use of AI in government operations, while intensifying competition among leading developers of the booming technology...
Handgards Acquires Albany Packaging USA
Handgards Acquires Albany Packaging USA
Sep 25, 2025
ROSEMONT, Ill.--(BUSINESS WIRE)-- Handgards, LLC (“Handgards”), a leading distributor of foodservice products and a portfolio company of Wynnchurch Capital, L.P. (“Wynnchurch”), today announced the acquisition of Albany Packaging USA (“Albany” or the Company). Headquartered in Deerfield Beach, Florida, Albany is a distributor of foodservice packaging, primarily paper folding cartons sold to supermarkets, bakeries, restaurants, and convenience stores. The Company’s products...
Form 8.3 - Alphawave IP Group plc
Form 8.3 - Alphawave IP Group plc
Sep 25, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Park West Asset Management LLC, investment adviser to the funds named in 1(b).   (b) Owner or controller of interests and short...
Copyright 2023-2026 - www.financetom.com All Rights Reserved